Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SIPULEUCEL-T for Prostate cancer: Side Effects & Safety Data

Prostate Health & Male Vitality — Naturally

ProstaVive: better flow, better sleep, better energy. 180-day guarantee.

Learn More

There are 1,720 adverse event reports in the FDA FAERS database where SIPULEUCEL-T was used for Prostate cancer.

Most Reported Side Effects for SIPULEUCEL-T

Side Effect Reports % Deaths Hosp.
Chills 447 9.7% 1 76
Infusion related reaction 414 9.0% 1 91
Pyrexia 255 5.5% 2 89
Fatigue 249 5.4% 6 51
Malaise 233 5.1% 8 52
Nausea 205 4.5% 4 45
Disease progression 185 4.0% 45 60
Ill-defined disorder 185 4.0% 2 9
Culture positive 174 3.8% 0 30
Asthenia 164 3.6% 11 75
Vomiting 159 3.5% 5 44
Back pain 141 3.1% 2 29
Dizziness 138 3.0% 4 44
Urinary tract infection 129 2.8% 5 75
Fall 121 2.6% 14 76

Other Indications for SIPULEUCEL-T

Prostate cancer metastatic (2,563) Product used for unknown indication (236) Hormone-refractory prostate cancer (33) Metastases to bone (6) Prostate cancer stage iv (5)

Other Drugs Used for Prostate cancer

LEUPROLIDE (45,399) ENZALUTAMIDE (25,954) RELUGOLIX (18,752) ABIRATERONE (12,209) APALUTAMIDE (3,286) GOSERELIN (2,080) DEGARELIX (2,035) BICALUTAMIDE (1,832) DENOSUMAB (1,627) DOCETAXEL (1,551)

Related Pages

SIPULEUCEL-T Full Profile All Prostate cancer Drugs SIPULEUCEL-T Demographics SIPULEUCEL-T Timeline